J B Briggs

Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.

J. Briggs, A. Jones, S. Chamow, 2001, Biochemistry.

Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics.

T. Raju, J. Briggs, S. M. Borge, 2000, Glycobiology.